SOX2 and glioma: A combination of SB273005 and TMZ, when administered orally, an advantageous delivery route 68, efficiently suppressed the activation of pro-tumor transcription factors SOX2 and Nestin expression, leading to superior tumor suppression and prolonged overall survival time in orthotopic glioma models 69, 70.